Global Health Limited , operating under the brand name Medanta, has reported strong financial results for the first quarter of fiscal year 2026, demonstrating significant growth across key metrics.

Financial Highlights

Medanta's total income for Q1 FY2026 reached INR 10,513.00 million, marking a substantial 19% year-on-year increase from INR 8,830.00 million in the same quarter last year. The company's EBITDA saw an impressive 23% growth, reaching INR 2,553.00 million, with an improved EBITDA margin of 24.30%.

One of the standout figures was the company's profit after tax (PAT), which surged by 50% to INR 1,590.00 million. The PAT margin also saw a notable improvement, rising to 15.10% from 12.00% in the corresponding quarter of the previous year.

Operational Performance

The company's operational metrics showed robust growth:

• Inpatient volumes increased by 14%
• Outpatient volumes grew by 13%
• Average occupied bed days rose by 13%
• Overall occupancy reached approximately 63% on increased bed capacity

The average revenue per occupied bed (ARPOB) for the quarter stood at INR 66,584.00, up 4% from INR 64,035.00 in Q1 FY2025.

International Patient Revenue

Medanta reported a significant 34% year-on-year increase in revenue from international patients, reaching INR 636.00 million for the quarter.

Expansion and Growth Initiatives

The company has made notable strides in its expansion plans:

• Operationalized a new 110-bed hospital in Ranchi in July 2025
• Poised to commence operations at the 550-bed Medanta Noida facility in the coming weeks
• Plans to add 2,000 beds over the next 3-4 years, with 1,000 beds in the near term

Mature vs. Developing Hospitals Performance

Mature Hospitals

Mature hospitals, primarily the Gurugram facility, saw an 11% year-on-year growth in total income, reaching INR 7,006.00 million. The EBITDA for mature hospitals grew by 7% to INR 1,640.00 million, with a margin of 23.40%.

Developing Hospitals

Developing hospitals, comprising Lucknow and Patna, demonstrated strong momentum with a 36% year-on-year growth in total income, reaching INR 3,219.00 million. EBITDA for these hospitals surged by 60% to INR 942.00 million, maintaining robust margins at 29.30%.

Management Commentary

Dr. Naresh Trehan, Chairman and Managing Director of Global Health Limited, emphasized the company's focus on delivering world-class, patient-centric care. He highlighted the onboarding of over 150 doctors, including 30 senior clinicians, to strengthen the medical team across specialties.

Pankaj Sahni, Group CEO, attributed the strong performance to the company's integrated care model and disciplined execution. He noted the significant growth in patient volumes and improved realizations, especially in the Gurugram unit.

Future Outlook

With the imminent launch of the Noida facility and ongoing expansion plans, Medanta is well-positioned for sustained growth. The company's focus on clinical excellence, operational efficiency, and strategic expansion initiatives suggests a positive outlook for the coming quarters.

As Global Health continues to strengthen its presence in key markets and enhance its medical capabilities, it remains committed to delivering high-quality healthcare services while driving financial growth.

Global Health Limited , operating under the Medanta brand, has reported robust financial results for the first quarter of fiscal year 2026, demonstrating significant growth across key metrics.

Financial Highlights

The company's consolidated total income for Q1 FY2026 reached ₹10,513.00 million, marking a substantial 19.10% year-on-year increase. This growth was primarily driven by higher patient volumes and improved realization.

EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) saw an even stronger performance, growing by 22.60% year-on-year to ₹2,553.00 million. The EBITDA margin improved to 24.30%, up from 23.60% in the same quarter last year.

Profit After Tax (PAT) showed remarkable growth, surging by 49.60% to reach ₹1,590.00 million. The PAT margin expanded significantly to 15.10%, compared to 12.00% in Q1 FY2025.

Operational Performance

Global Health's operational metrics also showed positive trends:

• Occupied bed days increased by 13.30%, reflecting an occupancy rate of 63.20% on an expanded bed capacity.
• Average Revenue Per Occupied Bed (ARPOB) grew by 4.00% to ₹66,584.00, driven by increased realization in the Gurugram unit and changes in specialty mix.
• In-patient volumes rose by 14.20%, while out-patient volumes increased by 13.10% year-on-year.

Segment Performance

Mature Hospitals

The company's mature hospitals (over 6 years old) saw revenue growth of 10.70% year-on-year, reaching ₹7,006.00 million. EBITDA for this segment grew by 6.70% to ₹1,640.00 million.

Developing Hospitals

Developing hospitals (less than 6 years old) demonstrated even stronger growth, with revenue surging by 35.90% to ₹3,219.00 million. EBITDA for this segment showed impressive growth of 59.80%, reaching ₹942.00 million.

Expansion and Future Outlook

Global Health continues to focus on expansion and capacity enhancement:

• A newly built 110-bed hospital in Ranchi was operationalized in July 2025.
• The company added 20 new beds at its Patna facility during the quarter.
• Construction of a 550-bed hospital in Noida is progressing, with operations expected to commence with 300 beds in Q2 FY2026.

Management Commentary

Commenting on the results, Mr. Pankaj Sahni, Group CEO and Director, said, "I am pleased to report another strong quarter, delivering our highest ever Total Income and EBITDA with year-on-year growth of 19% and 23% respectively. This robust performance was driven by increased patient volumes and improved realizations, with consistent growth across mature hospitals as well as Lucknow and Patna hospital."

He added, "Backed by a balanced portfolio of assets and a strong balance sheet, we are well-positioned to execute our long-term growth strategy and further expand the Medanta model of care across the region."

Global Health's strong Q1 FY2026 performance underscores its continued growth trajectory and successful expansion strategy in the healthcare sector.